Page last updated: 2024-08-24

estradiol 3,17-disulfate and Adrenocortical Carcinoma

estradiol 3,17-disulfate has been researched along with Adrenocortical Carcinoma in 1 studies

*Adrenocortical Carcinoma: A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aichler, M; Candida Villares Fragoso, M; Fassnacht, M; Feuchtinger, A; Gill, AJ; Herterich, S; Kircher, S; Kroiss, M; Kunzke, T; Ronchi, CL; Sbiera, S; Schlegel, N; Sun, N; Walch, A; Waldmann, J; Weigand, I; Whitsett, TG1

Other Studies

1 other study(ies) available for estradiol 3,17-disulfate and Adrenocortical Carcinoma

ArticleYear
Prognostic Relevance of Steroid Sulfation in Adrenocortical Carcinoma Revealed by Molecular Phenotyping Using High-Resolution Mass Spectrometry Imaging.
    Clinical chemistry, 2019, Volume: 65, Issue:10

    Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Biomarkers, Tumor; Child; Estradiol; Estrone; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Steroids; Sulfotransferases; Young Adult

2019